RxDoctor Payments Data

Mindi Dayton, DPM

Podiatrist · Ankeny, IANPI 1386846988

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $290,682 of the $333,027 with a category attached, or 87.3%. Treace Medical Concepts, Inc. accounts for 99.4% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $103,994 and has fallen 65.5% since, to $35,910 in 2025. Among podiatrist clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$333,027in general payments, 2019–2025

Across 290 payments — averaging $1148.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$331K
  • Fusion Orthopedics USA, LLC$886
  • Stryker$603
  • AbbVie$140
  • Orthofix Medical, Inc.$134
  • Integra Lifesciences Corporation$109
  • plus $289 from 7 others
$758in research payments, 2019–2025

Across 4 payments — averaging $189.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Treace Medical Concepts, Inc.$758

What the payments were for

  • Consulting fees$290,68287%
  • Speaking & faculty fees$120%
  • Travel & lodging$30,3959%
  • Food & beverage$11,8484%
  • Other$900%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$333,027 in reported general payments places this provider in the 95th percentile of 94 podiatrist providers in Iowa.

See all podiatrist providers in Iowa

Medicare billing

Part B allowed, 2024
$15,489
Medicare patients
55
Services billed
174

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other podiatrist in Ankeny

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →